Log in to your Inderes Free account to see all free content on this page.
Bio-Works Technologies
2.91 SEK
-1.02 %
Less than 1K followers
BIOWKS
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-1.02 %
+7.78 %
+11.07 %
+31.67 %
+2.46 %
+84.32 %
-79.50 %
-71.35 %
-66.13 %
Bio-Works Technologies operates in biotechnology. The company develops products that separate and purify molecules in the production of pharmaceuticals. The technology is based on chromatography, which is intended to handle the drug substance. Customers are found in the European market where the products are sold via distribution partners and to companies in the pharmaceutical industry, as well as research institutes and universities. The company was founded in 2006 and has its headquarters in Uppsala.
Read moreMarket cap
289.33M SEK
Turnover
262.08K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
13.5.
2026
Interim report Q1'26
4.6.
2026
General meeting '26
21.8.
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Bio-Works Technologies AB: Bio-Works publishes Year-end report Q4 2025
Bio-Works Technologies AB: Bio-Works Receives Order from Returning Customer
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio